Eps Diluted - JW (Cayman) Therapeutics Co Ltd (HKEX:2126) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1.82 HKD -1.09%

Updated:

JW (Cayman) Therapeutics Co Ltd
EPS (Diluted)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

JW (Cayman) Therapeutics Co Ltd
EPS (Diluted) Peer Comparison

6160

1801

603392

300122

300896

Company		EPS (Diluted)	CAGR 3Y	CAGR 5Y	CAGR 10Y
	JW (Cayman) Therapeutics Co Ltd HKEX:2126	EPS (Diluted) -¥1	CAGR 3-Years 47%	CAGR 5-Years -21%	CAGR 10-Years N/A
	Beigene Ltd HKEX:6160	EPS (Diluted) -¥10	CAGR 3-Years -25%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Innovent Biologics Inc HKEX:1801	EPS (Diluted) ¥0	CAGR 3-Years 4%	CAGR 5-Years 48%	CAGR 10-Years N/A
	Beijing Wantai Biological Pharmacy Enterprise Co Ltd SSE:603392	EPS (Diluted) ¥0	CAGR 3-Years -5%	CAGR 5-Years 12%	CAGR 10-Years N/A
	Chongqing Zhifei Biological Products Co Ltd SZSE:300122	EPS (Diluted) ¥3	CAGR 3-Years 22%	CAGR 5-Years 36%	CAGR 10-Years 39%
	Imeik Technology Development Co Ltd SZSE:300896	EPS (Diluted) ¥5	CAGR 3-Years 46%	CAGR 5-Years 63%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's EPS (Diluted) amounts to -1.9 CNY.

Over the last year, the EPS (Diluted) growth was 9%. The average annual EPS (Diluted) growth rates for JW (Cayman) Therapeutics Co Ltd have been 47% over the past three years , -21% over the past five years .

Join more than 135,500+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.